Insulet Corporation (NASDAQ:PODD)
Industry: Healthcare

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company offers Omnipod System, which consists of self-adhesive disposable tubeless Omnipod device (the pod) that delivers insulin into the body; and Personal Diabetes Manager, a handheld wireless device, which programs the Pod. It sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, Israel, and internationally. Insulet Corporation was founded in 2000 and is headquartered in Acton, Massachusetts.

Current Quote*
Last: $181.805
Change: -0.325
Book: $76.200
Volume: 36,608

As Of: 12/05 10:49 ET
*Quotes delayed by 20min.

Graphs for PODD

3 Month Graph

6 Month Graph

1 Year Graph